Skip to content
 
  • 1. About the programme
  • 2. Announcement
  • 3. Create application

Programme for Global Health and Vaccination Research (GLOBVAC)
Deadline Announcement
13.02.2013
13:00 CET 		Support for events Choose
13.02.2013
13:00 CET 		Approximately NOK 60 million available for Innovation Projects for the Industrial Sector Choose
05.09.2012
13:00 CET
Gjennomført 		Support for events Choose
19.04.2012
13:00 CET
Gjennomført 		NOK 160 mill. to global health and vaccination research – Call for full proposals Choose
30.11.2011
13:00 CET
Gjennomført 		NOK 160 mill. to global health and vaccination research – Call for project outlines Choose
04.06.2009
13:00 CET
Gjennomført 		Global Vaccination Research 2009 - General and Indo-Norwegian call Choose
03.09.2008
12:00 CET
Gjennomført 		Vaccination research 2008 part I - general call Choose
03.09.2008
12:00 CET
Gjennomført 		Vaccination research 2008 part II: Norwegian-Indian joint call Choose
16.04.2008
12:00 CET
Gjennomført 		Project establishment support Choose
01.04.2004
18:00 CET
Gjennomført 		Utlysning av forskningsmidler for 2004 Choose
Show only active

Objectives:

The primary objective of the Programme for Global Health and Vaccination Research (GLOBVAC) is to support high-quality research with potential for high impact that can contribute to sustainable improvements in health and health equity for poor people in low- and lower-middle income countries (LMIC).

Please note that low- and lower-middle income countries are defined in accordance with the OECD DAC list covering the following categories: least developed countries, other low-income countries, and lower middle-income countries and territories.

If other aspects of competing applications are considered equal, priority will currently be given to the African countries of Burundi, Ethiopia, Liberia, Madagascar, Malawi, Mali, Mozambique, Sudan, South Sudan, Tanzania, Uganda and Zambia; the Asian countries of Afghanistan, Nepal, Pakistan, Sri Lanka and East Timor; and the Palestinian Territories in the Middle East.

However, projects directed at other low- and lower-middle income countries are also encouraged.

Secondary objectives of the Programme are to:

  • develop and support internationally competitive and sustainable public and private research groups and institutions in Norway;
  • develop and support national and international research collaboration and partnerships;
  • secure capacity building through developing and supporting partnerships with research groups and institutions in low- and lower-middle-income countries;
  • inform and increase awareness among policymakers, researchers and the public about needs for and results from global health research.

The Programme prioritises projects in the following thematic areas:

1. Vaccine and vaccination research: all aspects of vaccine research, including epidemiology, diagnostics, discovery/vaccine design, development, evaluation/testing of vaccines, and delivery/implementation of vaccination strategies. In particular, research that can lead from pre-clinical to clinical testing, and participation in international product development, is encouraged. Examples of relevant research areas could be tuberculosis, HIV, MenA, diarrheal diseases and HPV.

2. Health systems and health policy research: i.e. production and application of knowledge to improve how societies organize themselves in order to achieve health goals and research on human resources, health services and health information systems.

3. Innovation in technology and methods development and innovation for the development of technology and methods that can contribute to meet the needs for patients and health personnel in resource-constrained conditions in low- and-lower middle-income countries where appropriate technologies are not available or non-existing. This includes developing products of high quality for prevention, diagnosis and treatment that are appropriate, accessible and affordable in resource-constrained conditions.

4. Implementation research: research on the promotion of uptake of research findings into public health programmes, and to expand knowledge on strategies for implementation and wider scaling-up of effective health interventions and health services. Research must be based upon and linked to health implementation activities in low-and lower-middle income countries.
 

For all thematic areas:

Potential synergies with the Norwegian Programme for Capacity Building in Higher Education and Research for Development (NORHED) are desirable, and should be explained in research proposals.

For further information about the GLOBVAC Programme, please see the Work Programme 2012-2020 in the menu.

This programme/activity normally accepts grant applications from:

Public Norwegian research institutions, private and independent Norwegian research institutions and Norwegian companies.

Duration:

2012-2020

Overall budget:

The annual budget of the Programme is currently NOK 70.5 million.

Related

See also

Vedlegg

Contact

Send to a friend

Your friend's e-mail:
Comment:

Your e-mail:

Your name:

Security check
Captchabilde